Clinical Trial Update: Postoperative Radiotherapy for Patients With IIIA (N2) Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update on postoperative radiotherapy for patients with IIIA (N2) non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Thoracic Neoplasms, Non-small Cell Lung Cancer | Phase 3 | Status: COMPLETED